Antiphospholipid syndrome: state of the art on clinical practice guidelines

TASK-FORCE REPORT [SDV]Life Sciences [q-bio] unmet needs 610 Autoimmunity European reference network 14TH INTERNATIONAL-CONGRESS 03 medical and health sciences 0302 clinical medicine 616 Medicine and Health Sciences MANAGEMENT EVIDENCE-BASED RECOMMENDATIONS ERN ReCONNET SYSTEMIC-LUPUS-ERYTHEMATOSUS ERN ReCONNET; European reference networks; antiphospholipid syndrome; clinical practice guidelines; unmet needs Unmet Needs antiphospholipid syndrome, clinical practice guidelines, ERN ReCONNET, European reference networks, unmet needs HCC MED Antiphospholipid Syndrome PREVENTION 3. Good health European Reference Networks EULAR RECOMMENDATIONS THROMBOSIS PREGNANCY antiphospholipid syndrome; clinical practice guidelines; ERN ReCONNET; European reference networks; unmet needs; Rheumatology; Immunology and Allergy; Immunology antiphospholipid syndrome; clinical practice guidelines; ERN ReCONNET; European reference networks; unmet needs ANTIBODIES Clinical Practice Guidelines antiphospholipid syndrome clinical practice guideline
DOI: 10.1136/rmdopen-2018-000785 Publication Date: 2018-10-18T23:15:34Z
ABSTRACT
Antiphospholipid syndrome (APS) is a rare disease characterised by venous and/or arterial thrombosis, pregnancy complications and the presence of specific autoantibodies called antiphospholipid antibodies. This review aims to identify existing clinical practice guidelines (CPG) as part of the ERN ReCONNET project, aimed at evaluating existing CPGs or recommendations in rare and complex diseases. Seventeen papers providing important data were identified; however, the literature search highlighted the scarceness of reliable clinical data to develop CPGs. With no formal clinical guidelines in place, diagnosis and treatment of APS is largely based on consensus and expert opinion. Patients’ unmet need refers to the understanding of the disease and its clinical picture and implications, the need of education for patients, family members and healthcare providers, as well as to the development of monitoring pathways involving multiple healthcare providers.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (35)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....